Author: therawinformant

  • 3 fantastic ASX 50 shares I would buy today

    man drawing upward curve on 2020 graph, asx share price growth

    The S&P/ASX 50 index is home to 50 of the largest shares on the Australian share market. These are predominantly household names and companies that are true blue chip shares.

    While not all shares on the index are necessarily in the buy zone, I think there are a few that could be.

    Here’s why I would buy these three outstanding ASX 50 shares:

    Aristocrat Leisure Limited (ASX: ALL)

    The first ASX 50 share to consider buying is Aristocrat Leisure. I’m a big fan of the gaming technology company due to the quality of both it poker machine and digital businesses. I believe both businesses have the potential to grow at an above-average rate over the long term thanks to their quality portfolios, high levels of investment in product design, and strong market positions. Combined, I expect solid earnings growth from Aristocrat Leisure for years to come once the pandemic passes. This could make it a top long term option.

    Rio Tinto Limited (ASX: RIO)

    Another ASX 50 share I would buy is Rio Tinto. I think the mining giant could be a great option for investors that are wanting to diversify their portfolio with a little exposure to the resources sector. Especially given the recent increase in the iron ore price. This looks to have positioned Rio Tinto perfectly to deliver bumper free cash flows from its world class operations in FY 2020 and FY 2021. And given the strength of its balance sheet, this is likely to lead to the miner rewarding shareholders with handsome dividends.

    Woolworths Limited (ASX: WOW)

    A final ASX 50 share which I think is worth considering is Woolworths. I’m a big fan of Woolworths due to its quality brands (Woolworths supermarkets, Dan Murphy’s, BWS), their defensive qualities, and its strong management team. I believe they have put the company in a position to generate robust earnings growth for the foreseeable future. And with Woolworths traditionally paying out a good portion of its profits as dividends, this bodes well for investors in search of income in this low interest rate environment.

    And listed below are more strong shares that look great value right now…

    3 “Double Down” stocks to ride the bull market higher

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has identified three stocks he thinks can ride the bull market even higher, potentially supercharging your wealth in 2020 and beyond.

    Doc Mahanti likes them so much he has issued “double down” buy alerts on all three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Woolworths Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 fantastic ASX 50 shares I would buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2Y9kYSh

  • Tencent Buying iQiyi Smells a Lot Like That Uber Deal

    from Yahoo Finance https://ift.tt/3hBdaR6

  • Why you should top up your super before June 30

    depositing coin into piggy bank for super, invest in super, grow super

    It’s mid-June and in Australia, that means cold mornings, strawberry moons and tax time preparations. Tax time can be a frantic time of year for a lot of Australians. And come 30 June 2020, the financial year (FY20) will be over and a new one about to start (FY21). We all need to be ready for that to happen – those deductions, subscriptions and donations to charity aren’t going to organise themselves.

    I’m sure many of us will be making our way to a Bunnings or Officeworks over the next fortnight – as shareholders of Wesfarmers Ltd (ASX: WES) are no doubt eagerly awaiting. 

    But there’s another bit of financial housekeeping that we could all look at to help us during tax time, and that’s the option to top up your super.

    I know, I know. No one likes super. I mean, most of us like that it’s there, but like children in days of yore, it’s often enjoyed ‘out of sight, out of mind’.

    But that doesn’t stop the fact that our super needs a little maintenance from time-to-time. And we happen to be at that special time of year!

    A super job before 30 June 

    Not only is a superannuation fund a savings and investment fund for our retirement, but it’s also something of a legal tax haven. See, most super contributions are taxed at a flat 15% rate, as opposed to most other income which can be taxed all the way up to 47 cents to the dollar. And so if you want to top up your super in the form of adding in extra cash above your employer’s minimum 9.5% (up to $25,000 a year in most cases), it will remain taxed at 15 cents in the dollar. This has the potential to save you a substantial amount in income tax if you do it properly.

    In order to claim this tax perk this financial year, you will have to top up your super before 30 June. Otherwise, it will count toward’s FY21’s cap rather than FY20’s.

    So, if you want to turbocharge your super fund’s compounding returns (and the chances of living your best retirement), think about making some concessional contributions before this date. Of course, it’s always a good idea to speak with your own tax agent or financial advisor to be sure this is the right option for you.

    Too many people aren’t taking full advantage of what topping up their super can do for them and I think it’s important to spread the word on how the FY20 tax time can help!

    For some shares you might want to buy with your tax return, make sure you check out the report below!

    5 ASX stocks under $5

    One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.

    Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why you should top up your super before June 30 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2Aydob7

  • This 5-Star Analyst Is Bullish on AMD’s Strong Roadmap

    This 5-Star Analyst Is Bullish on AMD’s Strong RoadmapThe last five years have been one unstoppable ride to the summit for chipmaker Advanced Micro Devices (AMD). Simultaneously closing the gap between its traditionally bigger rivals, Intel and Nvidia, and itself, the CPU/GPU maker is now most definitely a force to be reckoned with.Following an investor call with the company, Nomura analyst David Wong sees no reason to change tack when considering AMD as an investment.The 5-star analyst has a Buy rating on AMD shares to go along with a $64 price target. The implication for investors? Potential upside of 18% from current levels. (To watch Wong’s track record, click here)Behind AMD’s growth has been an exemplary roadmap. Still to come in 2020 is the launch of the highly anticipated Milan data center CPU, the third generation EPYC processor. Add to that the release of a new data center GPU “optimized on CDMA data center optimized architecture,” a new consumer GPU (Big Navi on RDNA 2), and Zen 3 desktop CPUs.AMD has stated its “product cadence” has been “condensed” so that new generations could hit the market every five or six quarters. Desktops and servers are usually first in line, followed by notebooks.“Given that AMD intends to launch a new generation of desktop and server CPUs near the end of 2020 and recently launched a new generation of notebook processors, this cadence implies that there may be a new generation of notebook processors in 2021 and a new generation of desktop and server processors in late 2021, or more likely the first part of 2022,” Wong said.The company’s aim of achieving between 20% to 30% year-over-year revenue growth in 2020 appears to be on track, too. In addition, despite the fact that this quarter’s ramp up of new semi-custom products for next-generation game consoles has had a “temporary impact” on gross margins, the chipmaker’s long-term goal of bringing in gross margins of over 50% hasn’t changed, either.Now let’s take a look at what the rest of the Street currently makes of AMD; Based on 12 Buys and 8 Holds, AMD has a Moderate Buy consensus rating. The analysts forecast a modest upside of 2%, should the $56.56 average price target be met over the next 12 months. (See AMD stock analysis on TipRanks)To find good ideas for tech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. More recent articles from Smarter Analyst: * Fulgent Pops 18% In After-Market On FDA Nod For Covid-19 Home Test * Amarin, Apotex Settle Vascepa Dispute; Analyst Stays Sidelined * Groupon Rises After-Hours Despite Revenue Plunging 35% Y/Y * Google and Carrefour Roll Out Voice-Based Shopping Service In France

    from Yahoo Finance https://ift.tt/2C5XkgX

  • 3 ASX growth shares to buy with $3,000

    growth shares

    If you have room in your portfolio for a few growth shares, then I think the three listed below could be top options.

    I believe all three are well-positioned to deliver above-average earnings growth over the next few years and could generate strong returns for investors. Here’s why I’m positive on them and would invest $3,000 across their shares:

    Bubs Australia Ltd (ASX: BUB)

    The first growth share to look at is Bubs. It is a goat’s milk-focused infant formula and baby food company. Whilst I’ve been a fan of Bubs for a while, it is only really now that I think it is investment grade. This is because for a long time its strong sales growth was coming with significant losses. This led to the company burning through cash at a rapid rate. However, Bubs recently reported positive operating cashflow of $2.3 million on record quarterly revenue of $19.7 million. I’m optimistic the company has now reached a scale which will make its operations more and more profitable over the coming years. As a result, I think it could be a good long term option for investors.

    Pro Medicus Limited (ASX: PME)

    Another growth share that I think has a lot of potential is Pro Medicus. This healthcare technology company provides radiology IT software and services to hospitals, imaging centres, and healthcare groups. The product in its portfolio that I’m most excited about is the popular Visage 7 Enterprise Imaging Platform. It delivers fast, multi-dimensional images which are streamed via an intelligent thin-client viewer. Demand for Visage 7 has been strong and the company recently announced a major new contract with one of the highest rated hospitals in the United States. In addition to this, it revealed that it has a number of sales opportunities in its pipeline that it is working on. I believe this bodes well for its future growth.

    Xero Limited (ASX: XRO)

    A final ASX growth share I think investors ought to consider buying is Xero. I think the provider of cloud-based business and accounting software is arguably one of best growth shares on offer on the ASX. This is due to the increasing demand for its platform from small businesses and the stickiness of its product. Combined, they are resulting in significant recurring revenues which I feel are only likely to grow larger in the coming years as more and more businesses move over to the cloud.

    And here are more exciting shares which could be stars of the future…

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of BUBS AUST FPO and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX growth shares to buy with $3,000 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fqC8Rc

  • AUD/USD Price Forecast – Australian Dollar Continues Choppy Behavior

    AUD/USD Price Forecast – Australian Dollar Continues Choppy BehaviorThe Australian dollar initially tried to rally during the trading session on Tuesday but gave back the gains as soon as we get close to the 0.70 level.

    from Yahoo Finance https://ift.tt/37zPRCu

  • Should You Avoid Momo Inc (MOMO)?

    Should You Avoid Momo Inc (MOMO)?The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

    from Yahoo Finance https://ift.tt/37tJgJY

  • Amarin, Apotex Settle Vascepa Dispute; Analyst Stays Sidelined

    Amarin, Apotex Settle Vascepa Dispute; Analyst Stays SidelinedAmarin (AMRN) has announced a settlement agreement with Apotex Inc. that resolves a patent litigation over Apotex’s abbreviated new drug application (ANDA) seeking US approval of a generic form of Vascepa capsules. Shares in Amarin rose 5% in Tuesday’s after-market trading.Amarin’s lead product Vascepa was initially launched in the US in 2013 as an adjunct therapy to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. A new, cardiovascular risk indication for the fish-oil derivative was approved by the FDA in December 2019 based on the results of the landmark Reduce-It trial.The company is currently appealing to the U.S. Court of Appeals a March 2020 patent invalidity ruling in favor of generic companies, Hikma Pharmaceuticals USA Inc. and Dr. Reddy’s Laboratories, Inc. Because Apotex is not a party to that litigation, it is not directly subject to related rulings.As part of the new settlement agreement, Apotex can not sell a generic Vascepa in the US until August 9, 2029 (the same date as Amarin’s 2018 settlement agreement with Teva (TEVA)) or earlier under certain customary circumstances.  These circumstances include if Amarin is not successful in its pending appeal of the March 2020 Nevada district court decision.The agreement also substantially resolves future litigation with Apotex that relating to the December 2019 cardiovascular risk reduction indication of Vascepa, says Amarin.“This settlement involves no financial payment from Amarin to Apotex and allows Amarin to avoid incremental litigation expense and distraction associated with Apotex’s participation in patent litigation related to the MARINE and REDUCE-IT indications,” said John F. Thero, Amarin CEO.Year-to-date shares in Amarin have plunged 68%, but analysts retain a cautiously optimistic Moderate Buy outlook on the stock. This breaks down into 7 recent buy ratings vs 5 hold ratings. Meanwhile the average analyst price target of $18 translates into 155% upside potential. (See Amarin stock analysis on TipRanks)Stifel Nicolaus analyst Derek Archila reiterated his Amarin Hold rating following the settlement announcement. “While this is a slight positive, we don’t see this a major stock moving catalyst” he wrote, adding that he expects AMRN shares to remain range bound until it gets closer to the critical appeal hearing later this year.Related News: Too Much Uncertainty Keeps This 5-Star Analyst Watching Amarin Stock From the Sidelines Jazz Pharma Scores Surprise Early Approval For Lung Cancer Treatment Merck’s Gardasil Receives FDA Nod For Expanded Cancer Indications More recent articles from Smarter Analyst: * Fulgent Pops 18% In After-Market On FDA Nod For Covid-19 Home Test * Groupon Rises After-Hours Despite Revenue Plunging 35% Y/Y * Google and Carrefour Roll Out Voice-Based Shopping Service In France * Facebook Unveils Tighter Political Ad Measures Ahead of US Elections

    from Yahoo Finance https://ift.tt/3ebRAAt

  • Fund managers have been buying these ASX shares

    ASX buy

    I like to keep an eye on substantial shareholder notices. This is because these notices give you an idea of which shares large investors, asset managers, and investment funds are buying or selling.

    Two notices that have caught my eye today are summarised below. Here’s what these fund managers have been buying:

    Computershare Limited (ASX: CPU)

    A notice of change of interests of substantial holder shows that AustralianSuper has taken advantage of Computershare’s share price weakness to increase its stake. According to the notice, the super fund has picked up approximately 8 million of this share registry company’s shares over the last four months. This has lifted its holding to a total of ~41.1 million shares, which represents a 7.59% stake in the company.

    The Computershare share price is down 27% from its 52-week high. Judging by its purchases, this has left its shares trading at a level that AustralianSuper thinks is attractive. One broker that would agree with this is Morgans. Last month the broker put an add rating and $13.90 price target on the company’s shares.

    Medibank Private Ltd (ASX: MPL)

    A notice of initial substantial holder reveals that Perpetual Limited (ASX: PPT) has been building a position in this private health insurer over the last few months. Perpetual started buying in February when Medibank’s shares were trading at $3.06. It then continued to purchase shares in March when they fell to ~$2.60 and has consistently added to its holding since then. Its last recorded purchase came on 11 June for $3.01. In total Perpetual now owns 140,759,820 shares, which represents a 5.11% stake in the company.

    As with AustralianSuper and Computershare, it appears as though the fund manager sees value in Medibank’s shares after they fell 18% from their high. Affordability issues have been weighing heavily on the company over the last 12 months, but AustralianSuper doesn’t appear concerned.

    And here are more quality shares which I think fund managers could be buying…

    5 ASX stocks under $5

    One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.

    Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Fund managers have been buying these ASX shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3dbzttb

  • 5 ASX shares that would’ve made you a fortune in 5 years

    Wealthy man with money raining down, cheap stocks

    Finding ASX shares that can make you a fortune in just 5 years is every investor’s dream. Investing in that one knockout winner can make a life-changing impact on your portfolio and your personal wealth. Of course, the ASX boards are littered with the broken dreams of those investors who’ve made the wrong bets. We can’t all find the next Amazon.com.

    But we can take a look at some past ASX winners that made their investors very rich over the past 5 years.

    CSL Limited (ASX: CSL)

    CSL is one of those rare shares that has made an absolute motza for its investors over the past 5 years, despite its size and blue chip status. Five years ago, CSL shares were trading at $87.40 each. Fast forward to today and CSL shares will set you back $286.22 (at the time of writing). That’s a 227% gain in 5 years.

    Xero Limited (ASX: XRO)

    Xero has been another ASX fortune maker over the past 5 years. This cloud-based accounting software provider was a slow burner in its infancy but has really stepped on the gas over the past few years, as its scalable business model works its magic. Five years ago, Xero shares were asking just $17.06. Today, those same shares will set you back $88.39. That’s more than 400% in gains that investors have enjoyed since 2015.

    Northern Star Resources Ltd (ASX: NST)

    It’s not often that ASX gold miners are cited as favoured money makers, but ask any Northern Star shareholder for their opinion on the matter. This mid-cap miner’s shares have spent the past 5 years rocketing from $2.28 in 2015 to $13.20 today. If you go back another 5 years to 2010, Northern Star was just 6 cents per share. Who said that gold doesn’t glitter! Any lucky shareholder that acquired Northern Star ownership in 2015 would be looking at nearly a 480% gain today. And for anyone who got in back in 2010? Hello 22,000%.

    Afterpay Ltd (ASX: APT)

    Afterpay’s phenomenal success would probably be familiar to every ASX investor by now. After all, this buy now, pay later pioneer is a share that is up more than 35% in just the last month alone. But what of those long-term investors in Afterpay? Well, back in 2015, you could have picked up Afterpay shares for just $2.95. Fast forward to today and Afterpay is making yet more record highs, going for $57.34 at the time of writing. That’s a 1,844% return since 2015. Talk about a fortune maker!

    Fortescue Metals Group Limited (ASX: FMG)

    Much like CSL, this ASX blue chip iron miner doesn’t immediately come to mind as a ‘multi-bagger‘ share. Yet this company’s numbers tell a different story. Back in 2015, you could have picked up some Fortescue shares for just $2.16. Today, those same shares will set you back $14.61 – netting any lucky buyer in 2015 a 576% increase in their fortune. Not bad for a red dirt digger.

    For some potential multi-baggers of tomorrow, make sure you check out the shares named below.

    3 “Double Down” stocks to ride the bull market higher

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has identified three stocks he thinks can ride the bull market even higher, potentially supercharging your wealth in 2020 and beyond.

    Doc Mahanti likes them so much he has issued “double down” buy alerts on all three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 5 ASX shares that would’ve made you a fortune in 5 years appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37FWljh